United States of America Continuous Glucose Monitoring Market ANALYSE DE LA TAILLE ET DU PARTAGE - TENDANCES DE CROISSANCE ET PRÉVISIONS (2024 - 2031)

United States of America Continuous Glucose Monitoring Market is Segmented By Components (Sensors, Transmitters & Receivers, Integrated System, Others), By Demographic (Adults (18-65), Geriatrics (65+), Pediatrics/ Teenagers), By Indication (Type 1 Diabetes, Gestational Diabetes, Type 2 Diabetes, Others), By End-User (Hospitals, Home Care, Clinics, Nursing Homes, Others). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of United States of America Continuous Glucose Monitoring Market

Les principaux acteurs opérant aux États-Unis d'Amérique Continuous Glucose Monitoring Market sont Abbott, Dexcom, Inc., Medtronic, Senseonics, Inc., F. Hoffmann-La Roche Ltd., GLUCOVATION, INC., Nemaura Medical Inc., GlySens, GlucoModicum et Signos, Inc.

United States of America Continuous Glucose Monitoring Market Leaders

  • Abbott
  • Dexcom, Inc.
  • Medtronic
  • Senseonics, Inc.
  • F. Hoffmann-La Roche Ltd.
*Disclaimer: Major players are listed in no particular order.

United States of America Continuous Glucose Monitoring Market - Competitive Rivalry, 2023

Market Concentration Graph

United States of America Continuous Glucose Monitoring Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights

United States of America Continuous Glucose Monitoring Market Report Snapshots

Buy Now